MK-8507

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8507, covering 2024-10-01 to 2024-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-8507 and Islatravir (MK-8591) in Healthy Adult Participants (MK-8507-016) [Phase 1]